bioRxivBiochemistry
Structural Basis for SARS-CoV-2 Envelope Protein in Recognition of Human Cell Junction Protein PALS1
J. Chai, Y. Cai, C. Pang, L. Wang, S. McSweeney, J. Shanklin, Q. Liu
Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 virus has created a global health and economic emergency. SARS-CoV-2 viruses hijack human proteins to promote their spread and virulence including the interactions involving the viral envelope (E) protein and human proteins. To understand the structural basis for SARS-CoV-2 viral-host recognition, we used cryo-electron microscopy to determine a structure for the human cell junction protein PALS1 and SARS-CoV-2 E protein complex. The structure shows that the E protein C-terminal DLLV motif recognizes a pocket formed exclusively by hydrophobic residues from the PDZ and SH3 domains in PALS1. Our structural analysis provides an explanation for the observation that the viral E protein recruits PALS1 from lung epithelial cell junctions resulting in vascular leakage, lung damage, viral spread, and virulence. In addition, our structure provides novel targets for peptide- and small-molecule inhibitors that could block the PALS1-E interactions to reduce the E-mediated damage to vascular structures.
- organism: human
- assay: cryo-EM
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein ZO1
A. Shepley-McTaggart, C. A. Sagum, … R. N. Harty·bioRxiv·Dec 22, 2020
- Interactions of SARS-CoV-2 protein E with cell junctions and polarity PDZ-containing proteins
Y. Zhu, F. Alvarez, … C. Caillet-Saguy·bioRxiv·Dec 4, 2021
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2
Flavio Alvarez, Florence Larrous, … Célia Caillet‐Saguy·Scientific ReportsPeer-reviewed·Dec 28, 2025
- Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
S. H. Park, H. Siddiqi, … S. J. Opella·bioRxiv·Apr 6, 2021
- A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ Binding Motif to the cytoplasm.
B. Neitthoffer, F. Alvarez, … B. Boeda·bioRxiv·Aug 29, 2023
- Structural insight into the putative role of novel SARS CoV-2 E protein in viral infection: a potential target for LAV development and therapeutic strategies
Manish Sarkar, Soham Saha·bioRxiv·May 11, 2020